Charles A. Peloquin

19.4k total citations · 1 hit paper
317 papers, 11.7k citations indexed

About

Charles A. Peloquin is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Charles A. Peloquin has authored 317 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Infectious Diseases, 168 papers in Epidemiology and 130 papers in Pharmacology. Recurrent topics in Charles A. Peloquin's work include Tuberculosis Research and Epidemiology (174 papers), Antibiotics Pharmacokinetics and Efficacy (126 papers) and Pneumocystis jirovecii pneumonia detection and treatment (63 papers). Charles A. Peloquin is often cited by papers focused on Tuberculosis Research and Epidemiology (174 papers), Antibiotics Pharmacokinetics and Efficacy (126 papers) and Pneumocystis jirovecii pneumonia detection and treatment (63 papers). Charles A. Peloquin collaborates with scholars based in United States, Saudi Arabia and South Africa. Charles A. Peloquin's co-authors include Abdullah Alsultan, William J. Burman, David E. Nix, Keith Gallicano, Eric L. Nuermberger, Shaun E. Berning, J Grosset, Andrew Vernon, Kathy N. Williams and Mohammad H. Al‐Shaer and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Charles A. Peloquin

305 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy

2006 814 citations Charles A. Peloquin, Timothy R. Sterling et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Charles A. Peloquin

Since Specialization

Citations

This map shows the geographic impact of Charles A. Peloquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles A. Peloquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles A. Peloquin more than expected).

Fields of papers citing papers by Charles A. Peloquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles A. Peloquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles A. Peloquin. The network helps show where Charles A. Peloquin may publish in the future.

Co-authorship network of co-authors of Charles A. Peloquin

This figure shows the co-authorship network connecting the top 25 collaborators of Charles A. Peloquin. A scholar is included among the top collaborators of Charles A. Peloquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles A. Peloquin. Charles A. Peloquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial 2025 ·The Journal of Infectious Diseases ·(unknown), Georgina Platt, Charles A. Peloquin, (unknown), Julia Coit, Gustavo E. Velásquez, Henry Pertinez, Diana Vargas, (unknown), Róger Calderón, Judith Jiménez, Karen Tintaya, David García, (unknown), Leonid Lecca, Carole D. Mitnick, Geraint Davies	0
2	Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial 2025 ·American Journal of Respiratory and Critical Care Medicine ·Patrick Phillips, Charles A. Peloquin, (unknown), (unknown), Andreas H. Diacon, Eduardo Gotuzzo, Debra Benator, Robin M. Warren, David Sikes, Leonid Lecca, Neel R. Gandhi, Elizabeth M. Streicher, (unknown), Kathleen D. Eisenach, Carole D. Mitnick, C. Robert Horsburgh	1
3	DIAGNOSIS AND MANAGEMENT OF NONTUBERCULOUS MYCOBACTERIAL INFECTIONS IN COLD-STUNNED KEMP'S RIDLEY SEA TURTLES (LEPIDOCHELYS KEMPII ): 16 CASES (2008–2023) 2025 ·Journal of Zoo and Wildlife Medicine ·(unknown), (unknown), L. Elaine Epperson, Reeti Khare, Michael Strong, Brian A. Stacy, (unknown), (unknown), Julie M. Cavin, (unknown), (unknown), (unknown), Salvatore Frasca, Mauricio Solano, Constance Merigo, (unknown), Charles A. Peloquin, (unknown), Charles J. Innis	0
4	Linezolid Dosing and Pharmacokinetics in North American Patients With Tuberculosis 2025 ·Clinical Infectious Diseases ·(unknown), Charles A. Peloquin, Connie A. Haley	2
5	Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs 2024 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maunank Shah, Elizabeth W. Tucker, Laurence Carroll, Joel S. Freundlich, Charles A. Peloquin, Vijay Ivaturi, Sanjay K. Jain	8
6	Therapeutic drug monitoring in cystic fibrosis and associations with pulmonary exacerbations and lung function 2023 ·Respiratory Medicine ·(unknown), (unknown), Cesar Trillo‐Alvarez, Mohammad H. Al‐Shaer, Charles A. Peloquin, Jorge Lascano	2
7	Linezolid does not improve bactericidal activity of rifampin-containing first-line regimens in animal models of TB meningitis 2023 ·International Journal of Antimicrobial Agents ·Elizabeth W. Tucker, Camilo A. Ruiz-Bedoya, Filipa Mota, Clara Erice, John Kim, (unknown), (unknown), (unknown), (unknown), (unknown), Charles A. Peloquin, Joel S. Freundlich, Sanjay K. Jain	6
8	Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs 2022 ·Journal of Clinical Investigation ·Riti Sharan, Shashank Ganatra, Dhiraj Kumar Singh, Journey Cole, Taylor W. Foreman, Rajesh Thippeshappa, Charles A. Peloquin, Vinay Shivanna, Olga González, Cheryl L. Day, Neel R. Gandhi, Edward J. Dick, Shannan Hall-Ursone, Smriti Mehra, Larry S. Schlesinger, Jyothi Rengarajan, Deepak Kaushal	10
9	Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies 2022 ·Nature Communications ·Filipa Mota, Camilo A. Ruiz-Bedoya, Elizabeth W. Tucker, Daniel P. Holt, (unknown), Martin A. Lodge, Clara Erice, (unknown), (unknown), (unknown), John Kim, (unknown), Alvaro A. Ordoñez, Charles A. Peloquin, Robert F. Dannals, Sanjay K. Jain	26
10	Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis 2021 ·Journal of Cystic Fibrosis ·(unknown), Charles A. Peloquin, Peter Hiatt, Michelle Mann, (unknown), (unknown), (unknown), (unknown), F. Ruiz	7
11	Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems 2020 ·Expert Opinion on Drug Metabolism & Toxicology ·Anne‐Grete Märtson, Gena Burch, Samiksha Ghimire, Jan‐Willem C. Alffenaar, Charles A. Peloquin	43
12	Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial 2019 ·PLoS Medicine ·Sara H. Browne, Anya Umlauf, (unknown), (unknown), Kathleen Moser, Juan González‐García, Charles A. Peloquin, Terrence F. Blaschke, Florin Vaida, Constance A. Benson	61
13	Noninvasive ¹¹ C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis 2018 ·Science Translational Medicine ·Elizabeth W. Tucker, (unknown), Alvaro A. Ordoñez, (unknown), Mariah H. Klunk, Richa Sharma, Yong S. Chang, (unknown), (unknown), Martin A. Lodge, Steven P. Rowe, Daniel P. Holt, Jogarao Gobburu, Charles A. Peloquin, William B. Mathews, Robert F. Dannals, Carlos A. Pardo, Sujatha Kannan, Vijay Ivaturi, Sanjay K. Jain	58
14	Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig 2010 ·Journal of Antimicrobial Chemotherapy ·Zahoor Ahmad, Eric Nuermberger, Rokeya Tasneen, Michael L. Pinn, Kathy N. Williams, Charles A. Peloquin, J Grosset, Petros C. Karakousis	42
15	Dose selection and pharmacokinetics of rifampin in elephants for the treatment of tuberculosis 2006 ·Journal of Veterinary Pharmacology and Therapeutics ·Charles A. Peloquin, Joel N. Maslow, Susan K. Mikota, Alan Forrest, Freeland Dunker, Ramiro Isaza, (unknown), (unknown), Min Zhu	8
16	Weekly Moxifloxacin and Rifapentine Is More Active Than the Denver Regimen in Murine Tuberculosis 2005 ·American Journal of Respiratory and Critical Care Medicine ·Ian M. Rosenthal, Kathy N. Williams, Sandeep Tyagi, Andrew Vernon, Charles A. Peloquin, William R. Bishai, J Grosset, Eric Nuermberger	42
17	Serum Concentrations of Antimycobacterial Drugs in Patients with Pulmonary Tuberculosis in Botswana 2005 ·Clinical Infectious Diseases ·Jordan W. Tappero, Williamson Z. Bradford, Tracy Agerton, Philip C. Hopewell, Arthur Reingold, Shahin Lockman, (unknown), Elizabeth A. Talbot, Thomas Kenyon, Themba Moeti, Howard Moffat, Charles A. Peloquin	123
18	Pharmacokinetics of Rifapentine at 600, 900, and 1,200 mg during Once-Weekly Tuberculosis Therapy 2004 ·American Journal of Respiratory and Critical Care Medicine ·Marc Weiner, Naomi Bock, Charles A. Peloquin, William J. Burman, Awal Khan, Andrew Vernon, Zhen Zhao, Stephen E. Weis, Timothy R. Sterling, Katherine Hayden, Stefan Goldberg	62
19	Pharmacokinetics of ethambutol in children and adults with tuberculosis. 2004 ·PubMed ·Min Zhu, W. J. Burman, Jeffrey R. Starke, Jerry Jean Stambaugh, P Steiner, (unknown), David Ashkin, Barbara Auclair, Shaun E. Berning, Roger W. Jelliffe, George S. Jaresko, Charles A. Peloquin	62
20	Long-Term Safety of Ofloxacin and Ciprofloxacin in the Treatment of Mycobacterial Infections 1995 ·American Journal of Respiratory and Critical Care Medicine ·Shaun E. Berning, Lorie A. Madsen, M D Iseman, Charles A. Peloquin	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact